To the IMSMP Family and Supporters of the Tisch MS Research Center of New York,  It gives me great pride and joy to announce that the FDA has approved our Phase I clinical trial for the use of bone marrow-derived neural stem cells in the treatment of multiple sclerosis. This exciting development is the culmination of a decade long effort by the dedicated team of scientists at the Tisch MS Research Center of New York at a cost of several million dollars. In treating patients with MS,...


Read about the latest discovery and advancement in MS research from the Tisch MS Laboratory.


One of our own neurologists, Dr. James Stark, spoke at Grand Rounds this morning. His talk focused on the clinical associations of CSF oligoclonal bands. The discussion ranged from diagnostic and prognostic issues to the immunologic implications as to the cause of MS. 


On Wednesday, June 12, 2013, Dr. Saud A. Sadiq and Dr. Violaine Harris met with a congressional supporter of our stem cell program. Following this discussion, The Tisch MS Research Center of New York submitted additional information to the FDA on June 18, 2013 and requested a formal meeting with the agency in the next 30 days.  We will keep you informed on the progress through an update on this website in approximately 6 weeks. 


Even if you feel that your symptoms are under control or if you’re experiencing long periods of time between relapses, learn why compliancy and failing to stick to your treatment plan can hasten the progression of MS. 


Beth DiBiase, Director of Social Work at the IMSMP, spoke at grand rounds this morning. Her talk was on the psychological impact MS has on our patients. The lecture was excellent and there was a prolonged discussion following, which involved every team in the center, from our administrative staff to physical therapy.


Check out an interview with Dr. Sadiq, titled "Stem Cells Hold Potential to Repair Immune Responses in MS Patients" featured on Science World Report.


Congratulations to Dr. Sadiq for his neurology listing in New York Magazine’s 2013 Best Doctor’s Issue! This is a great achievement and acknowledgement of the hard work and dedication that happens on a daily basis at the IMSMP and Tisch MS Research Center of New York!


Thursday, May 30, 2013: Dr. Sadiq presented his research on the experimental basis for stem cell therapy at the 2013 Consortium of Multiple Sclerosis Centers (CMSC) Annual Meeting held in Orlando, Florida.  For more on this conference go to:



Because you deserve only the best in MS healthcare. Experience the difference.

Newsletter Sign Up

Join our mailing list today!  Receive the latest information and updates happening in MS research, treatment and care including, Healing MS, the IMSMP newsletter.

* We don’t share your information with anyone.